In the research study, people with hyperacusis were super-responders, meaning they responded better than people with just tinnitus.
Well... if anybody doesn't want their spot or won't be able to make it (whether you changed your mind) I'd gladly take something earlier than 2020. I reached out in response to this "rumor" back on the 2nd of June, only to find out it's actually happening and so I did the form within 72 hours of its release. I waited and got the response above. It seems a lot of people are interested.
@Paulmanlike - sure, here they are:
It appears they are only doing business by appointment. Some people already have had their initial assessments and are pending the next appointment in which they will receive the device. Tinnitus Talk is tracking our own User Experience Group.
Not surprised since having random levels of tinnitus, my hyperacusis annoyance level is equal to that given tinnitus level.
First world? You're being way too generous man, we are in the dark ages.
How long do you use the device at home for? Nobody knows if tinnitus could get way better after, say, 6 months or a year of use, correct?
Which clinician - I will be driving 10 hours to be told it may not be suitable? Aargh.
They haven't been published yet, however, if I remember correctly, @annV still has a video and PowerPoint PDF of a presentation Neuromod gave where some of the results were being discussed.
Ross O'Neill said in the interview: "We defined hyperacusis as sound sensitivity to loudness discomfort levels (LDL) of 60 decibels sound level (dB SL) or less." So that's how they defined their hyperacoustic patients and this group responded the most to the device in terms of tinnitus improvement. However, their LDL levels did not improve enough to assume that the device improves pain-hyperacusis. (Question 4 in the interview with TinnitusHub: "Is the treatment more effective on tinnitus, hyperacusis, or both?")
Same here, it doesn't look like a summer launch in Germany and the UK is going to happen.
Agree. I think it will take many years to reach the third world countries. It's unlikely that people with mild / moderate tinnitus will spend so much money. It will only be an option for severe cases, so the market is small. And doctors prefer to offer TRT and other risk-free "therapies" that don't require training.
They have said in interviews they have a plan for their roll out beyond Ireland. Some of this is going to be dependent on approval from organizations like the FDA but they still have a plan.
It may well be they are waiting to see if they can get their trial data past peer review. That would tell them more about their likely future position, I guess, enabling them to make plans.
Good point. I had written to their "info" email address rather than appointments, but I guess the admins of the info email may not know corporate strategy. Still, putting in writing that they have no plan is curious. They could have said that they are preparing and will let us know later. Also, release in the EU should not be problematic, there is no FDA hurdle as Lenire is approved in the EU. The UK (well at least until Brexit) would be an ideal place to start for many reasons.
Are you sure you aren't misinterpreting their statement? They have to plan to rollout to the UK. They must have just said they can't give you an ETA yet (which is the same with the US).
Member
